Using remarkably efficient cloning techniques, South Korean researchers have created the first lines of embryonic stem cells customized to specific patients, a major advance that could accelerate the long-awaited dream of using genetically matched healthy cells to replace human cells and tissues damaged by disease and injury. Quotes Norm Fost, a medical ethicist and professor of pediatrics at the University of Wisconsin-Madison.
Office of Strategic Communication